Dans son discours du #BreakthroughPrize2024 👑, #CarlJune 🇺🇸, pionnier du traitement du #Cancer, a mis en avant les personnes les plus touchées par ses travaux révolutionnaires sur le développement de l’#ImmunoThérapie par cellules #CAR_T : les patients. linkedin.com/posts/universi…

Honorer la science salvatrice d'un scientifique de la vie #CarlJune 🇺🇸 et son co-bénéficiaire #MichelSadelain 🇫🇷 reçoivent le #BreakthroughPrize2024 👑 en sciences de la vie. Ses contributions innovantes à la #ThérapieCellulaire #CAR_Tcell ✂️ ont transformé l'approche du…

Honorer la science salvatrice d'un scientifique de la vie #CarlJune 🇺🇸 reçoit le #BreakthroughPrize 👑 en sciences de la vie Son co-bénéficiaire est #MichelSadelain 🇫🇷 du Sloan Kettering Memorial Hospital Leurs contributions innovantes à la #ThérapieCellulaire #CAR_T ✂️ ont…

Nel "toto #Nobel" per la Medicina, quest'anno - oltre al nome di Katalin #Karikò - c'era anche il nome di #CarlJune considerato il padre delle #CART. Questo è il suo ultimo studio: mira a rendere le cellule CAR-T ancora più precise ed efficaci.

Osservatorio Terapie Avanzate @TerapieAvanzate

7 months ago

Nel "toto #Nobel" per la Medicina, quest'anno - oltre al nome di Katalin #Karikò - c'era anche il nome di #CarlJune considerato il padre delle #CART. Questo è il suo ultimo studio: mira a rendere le cellule CAR-T ancora più precise ed efficaci.

0 4 3 484 1

#CarlJune, the Father of CAR T-Cell Therapy has won the 2024 Breakthrough Prize in Life Sciences. Learn more: buff.ly/48H2SJB #HealthTreeMM #myeloma #multiplemyeloma #mmsm

Penn Medicine’s Dr. Carl June has been named a winner of the 2024 Breakthrough Prize in Life Sciences for the development of chimeric antigen receptor (CAR) T cell immunotherapy. #pennmedicine #carljune #carttherapy Read more: penntoday.upenn.edu/news/penn-medi…

Carl June received the DKMS Mechtild Harf Science Award 2023 – @DKMS_SciMed #cancer #CarlJune #immunotherapy #scientists #oncology #oncodaily oncodaily.com/career/2787.ht…

#carljune said very #clearly

3-day CAR-T manufacturing with IL-18 secretion has great activity in some pts. #CarlJune #SU2CSummit2023

Les résultats d'une étude menée par #CarlJune de #PennMedicine donnent le feu vert pour l'application de la thérapie #CAR_T sous forme de gel aux plaies chirurgicales après l'ablation partielle de la #Tumeur pour éliminer les cellules tumorales résiduelles penntoday.upenn.edu/news/penn-medi…

#ash22 Immuneel Therapeutics @ 64th American Society of Hematology (ASH) Annual Meeting held at New Orleans, USA. Early results from IMAGINE study -first Phase 2 from INDIA presented on December 11-12, 2022.   #ash22 #Immuneel #cellandgenetherapy #drnoopurraje #carljune

⚡️ #CarlJune, pionnier du #CAR_T 🩸, parle de la création de #Startups et du prochain acte de la #ThérapieCellulaire. 👉 L’#Immunologiste de l’#UPenn et inventeur de #Kymriah s’est entretenu avec #BioPharmaDive sur l’avenir de la thérapie cellulaire. biopharmadive.com/news/carl-june…?

@purwarrahul2 @DrGauravNarula have started India’s CAR T-cell journey #APBMT22 #CARTcell therapy @IsbmtU From #EmilyWhitehead 1st patient to be treated by this amazing new therapy to present era - a decade long journey started at #CHOP @GruppSteve #CarlJune

Penn Medicine’s Dr. Carl June, has been named a 2022 Keio Medical Science Prize Laureate. He is recognized for his pioneering role in the development of CAR T cell therapy for cancer. #pennmedicine ##keioprize #carljune Read more: bit.ly/3UqxeZF

@ClaytonManship #Boomers are HORRIBLE! Yep, #VietnamWar, #CarlJune #PeggyWhitson #BillGates #OprahWinfrey #SteveWozniak #KentState Study "older generations more sensitive than younger generations" insider.com/baby-boomers-a…

👨‍⚕️ Transcribimos una #conferencia del Dr. Carl June, explicando cómo y porqué nacieron las células #CarT. · 🔻🔻 ARTÍCULO 🔻🔻 comunidadmielomamultiple.com/celulas-car-t.… · #CarlJune #Médico #Medicina#Mieloma #MielomaMúltiple #MielomaMultiple #cáncer #Amgen #Gsk #Takeda #JanssenESP #Celgene #mmsm